BOSTON—Calling it a “breakthrough for people who prefer their miracles non-visual,” researchers announced Tuesday that GLP-1 weight loss drugs are now clinically proven to improve your heart, liver, and overall sense of being cared for—while leaving your jeans in a long-term, stable relationship with your waistline.
“Look, not everyone loses weight, and that’s okay,” said one physician, gently patting a patient whose scale has not budged since the Obama administration. “What matters is that internally, your organs are thriving. Your liver is basically at a spa right now.”
The drugs, which famously silence cravings, have reportedly been less effective at silencing the scale for roughly 10–15% of users—now rebranded by pharmaceutical companies as “metabolically gifted responders.” Early genetic research suggests these patients may simply be “built different,” in the same way a brick wall is built different from a door.
“I don’t snack anymore, I feel amazing, and my cardiologist says my risk of a heart attack is way down,” said local man Greg T., adjusting a belt that has not required new holes. “Sure, I weigh the same, but spiritually? I’m down like 30 pounds.”
In response to growing evidence that GLP-1 drugs improve major health outcomes independent of weight loss, insurers are reportedly scrambling to update their policies, which previously required patients to lose at least 5% of their body weight or be cut off.
“We’re excited to expand coverage to include patients whose bodies are benefiting in ways we cannot immediately shame them for,” said one insurance executive, before clarifying that claims will still be denied if the patient’s organs appear “too relaxed.”
Pharmaceutical companies have embraced the shift, with new marketing campaigns expected to include slogans like “It’s What’s Inside That Counts,” and “Lose Inches Off Your Risk Profile, Not Your Waist.”
At press time, patients across the country were celebrating improved metabolic markers by eating a single bite of cake, feeling completely satisfied, and then staring at the remaining 99% of the slice with a mix of serenity and quiet betrayal.